Product

Tumor Infiltrating Lymphocyte

2 clinical trials

6 indications

Indication
Melanoma
Indication
Side Effects
Indication
Immunotherapy
Clinical trial
A Clinical Study on TIL for the Treatment of Advanced Melanoma
Status: Recruiting, Estimated PCD: 2024-09-25
Clinical trial
A Clinical Study on TIL for the Treatment of Advanced Hepatobiliary-Pancreatic Cancers
Status: Recruiting, Estimated PCD: 2024-09-25